View of Microbial Metabolites and Enzymes Inhibition in Drug Discovery and Development: A Case Study of the Statins, a Class of HMG-CoA Reductase Inhibitors

Editor-in-Chief, Prof. Abiodun Falodun (Profile)

Return to Article Details Microbial Metabolites and Enzymes Inhibition in Drug Discovery and Development: A Case Study of the Statins, a Class of HMG-CoA Reductase Inhibitors Download Download PDF

TJNPR Proudly Supports Open Access